Lanmar

Crispr Update (CRSP): Short term levels to get long

做多
Lanmar 已更新   
NASDAQ:CRSP   CRISPR Therapeutics AG
Entry is targeting the following
- Between the .382 - .618 retracement
- convergence with the 50 week moving average
- convergence with the 2 year trend-line

Original Analysis
评论:
New highs in the last week and now approaching a new weekly closing high end of this week. I have a strong feeling this will be the week it does that.

评论:
h&s .. add or get long spot
评论:
Next spot to add into. CRSP is ready for it's next leg higher:
评论:
We're at a decent swing target now. Of course CRSP could keep going too.. Stop can be adjusted to the following level:
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。